Article Text

PDF
Ewing family of tumours involving the vulva and vagina: report of a series of four cases
  1. W Glenn McCluggage1,
  2. Vaiyapuri P Sumathi2,
  3. Marisa R Nucci3,
  4. Michelle Hirsch3,
  5. Paola Dal Cin3,
  6. Michael Wells4,
  7. Adrienne M Flanagan5,
  8. Cyril Fisher6
  1. 1Department of Pathology, Royal Group of Hospitals Trust, Belfast, Northern Ireland
  2. 2Department of Musculoskeletal Pathology, The Royal Orthopaedic Hospital NHS Trust, Birmingham, UK
  3. 3Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, USA
  4. 4Department of Pathology, Sheffield University Medical School, Sheffield, England
  5. 5Institute of Orthopaedics and Musculoskeletal Sciences, Stanmore, Middlesex, UK
  6. 6Department of Pathology, Royal Marsden Hospital, London, UK
  1. Correspondence to:
 Professor W G McCluggage
 Department of Pathology, Royal Group of Hospitals Trust, Grosvenor Road, Belfast BT12 6BL, Northern Ireland; glenn.mccluggage{at}bll.n-i.nhs.uk

Abstract

Background: Ewing’s sarcoma and peripheral primitive neuroectodermal tumour (pPNET) are now regarded as two morphological ends of a spectrum of neoplasms, characterised by a t(11;22) or other related chromosomal translocation involving the EWS gene on chromosome 22 and referred to as Ewing family of tumours (EFTs). EFTs are extremely rare in the vulva and vagina, a review of the literature revealing only 13 previously reported possible cases, most of which have not had molecular confirmation. In this study, four new cases of EFTs involving the vulva (three cases) or vagina (one case) are reported.

Results: The tumours occurred in women aged 19, 20, 30 and 40 years and ranged in size from 3 to 8 cm. Morphologically, all neoplasms had a lobulated architecture and were composed of solid aggregates of cells. In one case, occasional rosettes were formed. In all the tumours, there was diffuse membranous staining with CD99; nuclear positivity with FLI-1 was present in two cases. Three cases were focally positive with the broad-spectrum cytokeratin AE1/3, all were diffusely positive with vimentin and all were desmin negative. In two cases, a t(11;22) (q24;q12) (EWSR1-FLI-1) chromosomal translocation was demonstrated by reverse transcriptase-PCR (one case) and fluorescence in situ hybridisation (FISH) (one case), and in another case a rearrangement of the EWSR1 gene on chromosome 22 was demonstrated by FISH. In the other case, a variety of molecular studies did not reveal a translocation involving the EWS gene but this tumour, on the balance of probability, is still considered to represent a neoplasm in the EFTs. Follow-up in two cases revealed that one patient developed pulmonary metastasis and died and another is alive without disease at 12 months.

Conclusions: This report expands the published literature regarding EFTs involving the vulva and vagina and stresses the importance of molecular techniques in firmly establishing the diagnosis, especially when these neoplasms arise at unusual sites.

  • EFTs, Ewing family of tumours
  • FISH, fluorescence in situ hybridisation
  • PNET, primitive neuroectodermal tumour
  • pPNET, peripheral PNET
  • RT-PCR, reverse transcriptase-PCR

Statistics from Altmetric.com

Footnotes

  • Competing interests: None declared

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.